Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

Clinical trial NCT06302569 · RECRUITING

Trial details

NCT number: NCT06302569
Sponsor: Giuseppe Procopio
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bellini Carcinoma Collecting Duct Carcinoma Renal Medullary Carcinoma

Start date: 2025-05-30
Primary completion: 2027-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.